Low molecular weight hydroxyethyl chitosan-prednisolone conjugate for renal targeting therapy synthesis, characterization and in vivo studies: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    11 August 2022

    • curprev 13:1713:17, 11 August 2022‎ 187.21.138.9 talk‎ 568 bytes +568‎ Created page with "== Target Article == Low molecular weight hydroxyethyl chitosan-prednisolone conjugate for renal targeting therapy synthesis, characterization and in vivo studies; X He, Z Yuan, X Wu, C Xu, W Li; 2012; doi_citing_unknown == Retraction == Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats ; R G F Haverdings M Haas G J Navis A M A Van Loenen-Weemaes D K F Meijer D De Zeeuw F Moolenaar; 08/01/2002 ;..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Low_molecular_weight_hydroxyethyl_chitosan-prednisolone_conjugate_for_renal_targeting_therapy_synthesis,_characterization_and_in_vivo_studies"